Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic

View ORCID ProfileFlavia Riccardo, Marco Ajelli, Xanthi D Andrianou, View ORCID ProfileAntonino Bella, View ORCID ProfileMartina Del Manso, View ORCID ProfileMassimo Fabiani, View ORCID ProfileStefania Bellino, Stefano Boros, View ORCID ProfileAlberto Mateo Urdiales, View ORCID ProfileValentina Marziano, View ORCID ProfileMaria Cristina Rota, View ORCID ProfileAntonietta Filia, View ORCID ProfileFortunato Paolo D’Ancona, View ORCID ProfileAndrea Siddu, View ORCID ProfileOrnella Punzo, Filippo Trentini, View ORCID ProfileGiorgio Guzzetta, View ORCID ProfilePiero Poletti, View ORCID ProfilePaola Stefanelli, View ORCID ProfileMaria Rita Castrucci, Alessandra Ciervo, Corrado Di Benedetto, Marco Tallon, View ORCID ProfileAndrea Piccioli, View ORCID ProfileSilvio Brusaferro, View ORCID ProfileGiovanni Rezza, View ORCID ProfileStefano Merler, Patrizio Pezzotti, for the COVID-19 working group
doi: https://doi.org/10.1101/2020.04.08.20056861
Flavia Riccardo
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Flavia Riccardo
  • For correspondence: flavia.riccardo@iss.it
Marco Ajelli
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xanthi D Andrianou
1Istituto Superiore di Sanità, Rome, Italy
3Cyprus University of Technology, Limassol, Cyprus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonino Bella
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonino Bella
Martina Del Manso
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martina Del Manso
Massimo Fabiani
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Massimo Fabiani
Stefania Bellino
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefania Bellino
Stefano Boros
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Mateo Urdiales
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Mateo Urdiales
Valentina Marziano
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Valentina Marziano
Maria Cristina Rota
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Cristina Rota
Antonietta Filia
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonietta Filia
Fortunato Paolo D’Ancona
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fortunato Paolo D’Ancona
Andrea Siddu
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Siddu
Ornella Punzo
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ornella Punzo
Filippo Trentini
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgio Guzzetta
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giorgio Guzzetta
Piero Poletti
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Piero Poletti
Paola Stefanelli
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paola Stefanelli
Maria Rita Castrucci
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Rita Castrucci
Alessandra Ciervo
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corrado Di Benedetto
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Tallon
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Piccioli
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Piccioli
Silvio Brusaferro
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Silvio Brusaferro
Giovanni Rezza
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanni Rezza
Stefano Merler
2Bruno Kessler Foundation, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefano Merler
Patrizio Pezzotti
1Istituto Superiore di Sanità, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Background In February 2020, a locally-acquired COVID-19 case was detected in Lombardia, Italy. This was the first signal of ongoing transmission of SARS-CoV-2 in the country. The outbreak rapidly escalated to a national level epidemic, amid the WHO declaration of a pandemic.

Methods We analysed data from the national case-based integrated surveillance system of all RT-PCR confirmed COVID-19 infections as of March 24th 2020, collected from all Italian regions and autonomous provinces. Here we provide a descriptive epidemiological summary on the first 62,843 COVID-19 cases in Italy as well as estimates of the basic and net reproductive numbers by region.

Findings Of the 62,843 cases of COVID-19 analysed, 71.6% were reported from three Regions (Lombardia, Veneto and Emilia-Romagna). All cases reported after February 20th were locally acquired. Estimates of R0 varied between 2.5 (95%CI: 2.18-2.83) in Toscana and 3 (95%CI: 2.68-3.33) in Lazio, with epidemic doubling time of 3.2 days (95%CI: 2.3-5.2) and 2.9 days (95%CI: 2.2-4.3), respectively. The net reproduction number showed a decreasing trend starting around February 20-25, 2020 in Northern regions. Notably, 5,760 cases were reported among health care workers. Of the 5,541 reported COVID-19 associated deaths, 49% occurred in people aged 80 years or above with an overall crude CFR of 8.8%. Male sex and age were independent risk factors for COVID-19 death.

Interpretation The COVID-19 infection in Italy emerged with a clustering onset similar to the one described in Wuhan, China and likewise showed worse outcomes in older males with comorbidities. Initial R0 at 2.96 in Lombardia, explains the high case-load and rapid geographical spread observed. Overall Rt in Italian regions is currently decreasing albeit with large diversities across the country, supporting the importance of combined non-pharmacological control measures.

Funding routine institutional funding was used to perform this work.

INTRODUCTION

SARS-CoV-2 infection in humans causing clusters of severe pneumonia (1–3) was first detected in the city of Wuhan, China, in December 2019. This pathogen was confirmed as a new virus by the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses. Based on phylogeny, taxonomy and established practice, they designated it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).(4) Although of probable zoonotic origin, human-to-human transmission is rapidly fuelling the spread of SARS-CoV-2 infections globally, with the main known routes of transmission being droplet and fomites.

The infection spread within China and rapidly across countries, with cases in Europe initially limited to small clusters in Germany, France (5,6) and the UK (7). On the 20th of February 2020, the first case of locally acquired SARS-CoV-2 infection was diagnosed in Northern Italy in a critically ill, hospitalized young man with no travel history to known areas of viral circulation or link to a probable or confirmed COVID-19 case. Prior to this date, only three cases of COVID-19 had been reported in Central Italy, all with a travel history to Wuhan.

Following this unexpected finding, extensive contact tracing and testing of close contacts unveiled ongoing transmission in several municipalities of the Lombardia region (8,9). In subsequent days and weeks, case counts, and death tolls increased rapidly, at first in northern Italy and then in the rest of the country. The Italian government imposed increasingly strict physical distancing measures starting with the closure of 10 municipalities in the Lodi Province (Lombardia) and one in the Padua province (Veneto) on the 23rd of February 2020. This culminated with a national lock-down on the 11th of March 2020. (10,11)

In this paper, we summarize key epidemiological findings from data on the first 62,843 confirmed COVID-19 cases in Italy, including 5,541 associated deaths, and initial findings on SARS-CoV-2 transmissibility across different regions.

METHODS

The Italian integrated COVID-19 surveillance system

With the aim to increase the understanding of the disease dynamics in Italy and support the planning of public health actions, a case-based surveillance system was established on the 27th of February 2020, building on a previously existing surveillance system focused only on suspected and confirmed COVID-19 severe respiratory infections (12). The system contains data on all laboratory confirmed cases of COVID-19 as per the case definition published and regularly updated online by the European Centre for Disease Prevention and Control (ECDC) (13).

Laboratory confirmation by RT-PCR on nasopharyngeal swabs is performed at regional level, as previously described (9,14). From the beginning of the outbreak until the 1st of March 2020, all initially confirmed cases were sent for final confirmation at the National Reference Laboratory in the Istituto Superiore di Sanità (ISS) and re-confirmed according to the World Health Organization guidelines using RT-PCR protocols described by Corman et al. (15) and by the US-CDC (16). Due to the high concordance (99%) among confirmation results with the engaged laboratories, the policy was then changed allowing selected Regions with demonstrated confirmation capacity to directly confirm COVID-19 cases (17). Data is collected daily using a secure online platform or, alternatively, received as individual datasets from the 19 regions and two Autonomous Provinces (AP) of the Italian territory, according to an increasingly harmonized track-record. Data collected includes information on: demographics, clinical severity, comorbidities, date of symptom onset, date of diagnosis, outcome, region of diagnosis and province of residence.

Clinical severity was defined as follows: (i) asymptomatic - a person found positive for SARS-CoV-2 with no apparent signs or symptoms of disease, (ii) paucisymptomatic - a person found positive for SARS-CoV-2 with general mild symptoms (e.g. with general malaise, low grade fever, tiredness etc.) but no clear signs of disease, (iii) mild - a person found positive for SARS-CoV-2 with clear signs and symptoms of disease (e.g., respiratory disease) but not severe enough to require hospitalisation, (iv) severe - a person found positive for SARS-CoV-2 with clear signs and symptoms of disease (e.g. respiratory disease) and severe enough to require hospitalisation, and (v) critical - a person found positive for SARS-CoV-2 with clear signs and symptoms of disease (e.g., respiratory disease) and severe enough to require admission to an Intensive Care Unit (ICU).

The surveillance system captures whether the reported subject is a Health Care Worker (HCW). We have defined a HCW broadly as a person who has ever worked in the Health Care sector regardless of role, profession or current working status. The system also records whether the affected person has one of the following comorbidities: cardio-vascular diseases, respiratory diseases, diabetes, immune-deficiencies, metabolic diseases, oncologic diseases, obesity, kidney diseases or other chronic diseases.

We have defined COVID-19 associated deaths as any person who has died and was confirmed to be infected with SARS-CoV-2.

Data is harmonized in a single dataset, cleaned and analysed daily to produce an infographic with main surveillance outputs. A more detailed bulletin is published bi-weekly. These outputs are publicly available on the web portal of Epidemiology of the ISS (18).

Statistical analysis

In total, 62,843 cases were included in the analysis (data extracted on March 24, 2020). The data was summarized by age group and sex. Epidemic curves were made by date of diagnosis and of symptom onset. Cases were aggregated by region/AP of diagnosis and by province of residence for cases residing in the same region/PA of diagnosis. Attack rates per 100,000 population by region/PA were calculated using population estimates for 2019, available from the Italian National Institute of Statistics (Istituto Nazionale di Statistica; ISTAT) and adjusted using the age distribution of the Italian population as a reference. We classified the attack rates in each region as high, intermediate and low based on the inter quartile range (IQR) of the adjusted attack rates as follows: (i) high: attack rates higher than the upper limit of the IQR; (ii) intermediate – within the IQR; (iii) low – lower than the lower limit of the IQR.

Case fatality rates (CFR), not accounting for delays, were calculated by age and sex and smoothed with the locally weighted regression method. CFRs by age were also calculated by calendar period of diagnosis (i.e., before 4th, 4-10, 11-17, 18-24 of March). A multilevel (clustered by Region/AP) multivariable logistic model was applied to evaluate characteristics associated with death, including age group (i.e., ≤40, 40-49, 50-59, 60-69, 70-79, 80-89, 90+ years), sex, HCW status, and week of diagnosis. Adjusted odds ratios were estimated. The analyses were performed using STATA (version 16) and R (version 3.6.3). The list of the R packages used for the analysis is available in the supplementary materials.

Transmission dynamics

As described previously (9), we define the basic reproduction number R0 as the average number of secondary cases that are generated in a fully susceptible population by a primary infector. This is an expression of the potential for transmission without any containment measure. However, once interventions are introduced or the susceptibility in the population decreases, the transmission potential at a given time t is measured as the net reproduction number Rt. In this paper, we estimated both R0 and Rt for Italian regions in different epidemiological situations (high, intermediate and low age-adjusted attack rates), selected among those with highest data robustness. We used a previously described Bayesian approach (19–21), informed by estimates of the serial interval from contact tracing data in Lombardia (9). We defined the serial interval as the distribution of the time from symptoms onset in a primary infector and the symptoms onset in secondary cases and estimated it on average to be 6.6 days. Details are reported in the supplementary materials.

RESULTS

As of the 24th of March 2020, 62,843 confirmed cases of COVID-19 had been reported including 5,541 related deaths, and the number of reported cases was increasing (Figure 1). Locally acquired cases diagnosed at the end of February reported onset of symptoms from the 28th of January onwards, indicating undetected local transmission for at least three weeks before detection. The average delay between symptom onset and diagnosis in the first month of the outbreak was 5.3 days.

Figure 1
  • Download figure
  • Open in new tab
Figure 1 Epidemiological curves of COVID-19 cases by date of onset (blue) and date of diagnosis (green), Italy 22 January – 24 March 2020

By March 24, 2020, all of Italy’s 21 regions and APs had reported at least one locally acquired case of COVID-19. The country had high incidence areas with sustained local transmission (mainly in the north), low incidence areas with limited but growing numbers of locally acquired cases of infection and regions with intermediate incidence (Figure 2). Overall, 98% of 29,938 COVID-19 cases diagnosed in Lombardia, were among people residing in this Region. Among the remaining 2% for which the residence of the case was known, most (94 cases) resided in the neighbouring region of Emilia Romagna. The index case of the outbreak was not found, and no clear chains of transmission were identified linking initial cases in newly affected regions/AP.

Figure 2
  • Download figure
  • Open in new tab
Figure 2 COVID-19 attack rates per 100,000 population (age-adjusted) by region/AP of diagnoses (a), number of cases, by region/AP of diagnosis -data available for 62,843 cases (b) and number of cases by municipality of residence when in the same region of diagnoses-data available for 59,128 cases (c), Italy, 24 March 2020

Age –adjusted attack rates per 100,000 were classified as high in Lombardia (crude attack rate 303.6 and age-adjusted attack rate 305.2 per 100,000), Valle d’Aosta, Trento, the region of Emilia-Romagna bordering Lombardia and in the Marche region in central Italy. Age –adjusted attack rates were classified as intermediate in Bolzano/Bozen, Veneto, Piemonte, Liguria, Friuli-Venezia Giulia, Abruzzo, Toscana, Umbria, Molise and Puglia. In Lazio, Campania, Sardegna, Calabria, Sicilia and Basilicata age –adjusted attack rates were classified as low (Figure 2 and Table 1, supplementary material).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1 Estimated epidemic doubling time and R0 in selected Italian Regions (data up to March 24, 2020).

Most affected cases were male (58%) and the median age of cases was 63 years. Notably, 5,760 cases were reported among health care workers (median age 49 years, 35.5% male).

Among cases with known age, clinical severity was reported for 15,940 cases. As shown in Figure 3, the proportion of severe cases in under 7 years of age was below 20%. This proportion decreased to 1.5% in the 7-19 year age group, then increased again gradually to 31.9% in the age group 80-89 years. Critical severity was reported in cases aged 20 years and above, reaching 8% in the 60-69 year age segment (Table 2, supplementary material).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2 Reported clinical severity of COVID-19 cases (n= 15,940) by Age Group, Italy, 24 March 2020
Figure 3
  • Download figure
  • Open in new tab
Figure 3 Reported clinical severity of confirmed COVID-19 cases, Italy (N=15 940)

Among all cases, 36,893 (58.7%) were reported to have been managed at home and 9,719 (15.5%) were hospitalised. For 16,231 (25.8%) cases this information was not available. As shown in Figure 4 (a), the proportion of hospitalised COVID-19 cases decreased from 0-1 to 7-19 years of age and increased progressively from 20-29 to 70-79 years of age when it appeared to stabilize. Figure 4 (b) shows, among all reported hospitalised COVID-19 cases with known unit of admission and age (N= 7,931), the proportion of patients admitted in ICU vs those admitted to any other hospital unit. Overall, the ICU admission rate was 11.2% considering only cases for which admission hospital unit was reported. Among all cases reported to have been hospitalised, the ICU admission rate was 9.1%. ICU admissions were reported from the 20-29 age group onwards, increasing in proportion until ages 60-69 years. The proportion decreases in older age groups.

Figure 4
  • Download figure
  • Open in new tab
Figure 4 Reported proportion of COVID-19 cases by home vs hospital management (N= 46,506) (a) and proportion of hospitalized COVID-19 cases (N= 7,931) by ICU vs other Unit of hospitalisation, by age group (b), Italy, 24 March 2020

Of the 5,541 reported COVID-19 associated deaths, 49% occurred in cases aged 80 years or above with an overall crude case fatality rate (CFR) of 8.8% (Table 3, supplementary material). Overall, 15 deaths were reported in HCW.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3 Distribution of diagnosed COVID-19 cases (n= 62,843) and related deaths (n= 5,541) by age and sex

Until March 24, 2020, no deaths were reported among cases aged less than 30 years. Overall, 68% of the people who died were reported to have at least one co-morbidity. Figure 5 shows the CFR reported as of the 24th of March 2020 by single age of diagnosed cases stratified by sex smoothed using locally weighted regression curves. There was a strong association of the CFR with age. Women had a lower CFR at each age point.

Figure 5
  • Download figure
  • Open in new tab
Figure 5 Case fatality rate by age at diagnosis and sex (dots (blue for males, reds for females) represent rates by single age, locally weighted regression curves (band width=0.8) show the estimated trend.

When stratifying by age group and calendar period of diagnosis we confirmed the age effect on the CFR but also showed that CFR increases with time since diagnosis, with an overall CFR of 19% for people diagnosed with COVID-9 before the 4th of March (Table 4, supplementary material).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4 Case fatality rate by age group and calendar period of COVID-19 diagnosis

After adjusting for age, sex, HCW profession, and calendar period of diagnosis, we estimated a higher adjusted odds ratios (AOR) of death with increasing age decade and a higher AOR for males compared to females. Health care workers (HCW) diagnosed with COVID-19 had lower AOR of death compared to the non HCW (Table 5, supplementary material). We performed additional models evaluating a possible interaction between sex and age group and between being a HCW and both age and sex. However, these did not provide a better fit to the data (p=0.06, p=0.91, p=0.26 log-likelihood ratio test, respectively). Similar results were found when restricting the analysis to cases aged 20-70 years old.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 5 Adjusted odds ratios (from multilevel logistic model clustered on reporting regions/autonomous provinces) of death in Italian COVID-19 reported cases to the Italian National surveillance (extracted March 24, 2020)

We estimated the transmission patterns for six Italian Regions (Lombardia, Veneto, Emilia-Romagna, Toscana, Lazio, and Puglia) with adjusted AR classification ranging from low to high. These six Italian Regions are characterized by highly different epidemic trajectories. The variability is also clearly visible in terms of epidemic doubling time, which varies between 2.7 days (95%CI: 2.3-3.3) in Emilia Romagna and 3.2 days (95%CI: 2.5-4.2) in Veneto (Table 1), and basic reproductive numbers, which lie in the range 2.13-3.33.

In Lombardia, we estimated the net reproduction number (Rt) to be above the epidemic threshold since late January 2020 (Figure 6). In February, the Rt started to oscillate reaching maximum values around 3 over the week from February 17 to 23. Starting from February 24, with the enforcement of a quarantined area around the most affected municipalities of the region, Rt was estimated to follow a constantly decreasing trend. The second and third most affected regions in February (Veneto and Emilia Romagna) show an increasing trend of Rt until about February 24 (Figure 6). At that time a few tens of cases had been detected in those regions.

Figure 6
  • Download figure
  • Open in new tab
Figure 6 COVID-19 estimated Rt and 95%CI in selected Italian regions, February-March 2020, over a 4-day moving average.

The transmission patterns of Toscana, Lazio, and Puglia are markedly different. In Central and South Italy, where Tuscany, Lazio, and Apulia are located, the epidemic spread was largely undetected until early March. After an initial increase, Rt remained nearly constant at values around 2.5-3 until March 4-8, when blanket physical distancing measures began being implemented at national level (Figure 6).

DISCUSSION

COVID-19 emerged in Italy with a similar clustering onset to the one described in Wuhan, China (2) with three major clusters around the cities of Codogno, Bergamo and Cremona in the Lombardia region in northern Italy (9). Subsequently, cases spread across the country with more sustained transmission in neighbouring regions in the north and in the central region of Marche. We estimated R0 in the range of 2.13-3.33 in different Italian regions with doubling time estimated between 2.7 and 3.2 days. This, alongside the short serial interval of COVID-19 in Italy (6.6 days on average) and the fact that the outbreak was detected amid ongoing transmission that had started at least three weeks earlier, explains the rapid case increase and geographical spread. It also explains the inability to identify the index case and clearly trace the initial spread of infection across the country.

Notably, in northern regions (Lombardia, Veneto and Emilia-Romagna), the net reproduction number Rt shows a marked decreasing trend since the identification of the first cases in late February. The observed decrease of Rt in northern regions is possibly due to increased population awareness and to the early effect of interventions. In other parts of the country, such as in central (Toscana, Lazio) and southern regions (Puglia), transmission was largely undetected until the first days of March, with Rt decreasing after the initial implementation of national blanket physical distancing measures.

Cases were for the most part detected in the same region/AP in which they reside. Most initial cases that did not reside in Lombardia resided in neighbouring Emilia-Romagna. This could be related to the fact that initial clusters occurred in industrial hubs with strong cross-border connections with neighbouring provinces in other regions, possibly favouring the rapid geographical spread of the infection in the north of the country.

Reported clinical severity was confirmed to be lowest among children, and in particular in the 7-19 years age group. The proportion of severe and critical cases increases with age until age 80 or above. The slight decrease in the proportion of critical and severe cases, and of deaths, in the higher age groups might be due to the demographic structure of the population with a higher female to male ratio among older people (22).

The proportion of hospitalized COVID-19 cases appears to follow a similar trend with age. Hospitalisation rates decreased from infancy to childhood and adolescence to increase again progressively with age among adults stabilizing from the 70-79 years age group.

Overall, the ICU admission rate based on reported data ranged between 9.1% and 11.2% depending on the denominator used. Both rates are much higher than the reported 4% in 16 European Union countries disclosed by the European Centre for Disease Prevention and Control (ECDC) (23). We are unable at this stage to speculate whether the reasons behind this difference are related with hospitalisation policies and practices or whether there are other factors at play. However, this observation confirms recent studies in Lombardia that highlight the potentially catastrophic effects of an uncontrolled COVID-19 epidemic on the healthcare system (8,9). Consistently with reported clinical severity, ICU admissions were notified starting from the 20-29 years age segment, suggesting the potential for critical disease also among young adults. The proportion of COVID-19 related ICU admissions, increases until the 60-69 years age segment to decrease in older ages apparently more rapidly than the reported stabilization of more severe disease in the same age groups. This pattern, however, might simply reflect lack of completeness of the surveillance data available at this stage. Further analysis on a larger number of records is required to confirm this finding.

As shown previously in China (24), we also demonstrated worse outcomes in older males with comorbidities. Male sex and older age are independent risk factors for COVID-19 related deaths. The CFR of 8.8% documented overall in Italy, is higher than that observed in other countries. As recently described, this could be in part explained by the demographic structure of the Italian population (25). However, other aspects such as testing policies and the surveillance system characteristics, including the choice in Italy to count only laboratory confirmed cases and to define associated deaths in a very inclusive manner, may also play a role in making initial case fatality data poorly comparable across countries. It is however noteworthy to stress that the early phase of the COVID-19 epidemic in Italy is characterized by a large number of cases with a short follow-up time since diagnosis. This implies that the overall CFR is currently largely underestimated. This was confirmed when performing an analysis by period of diagnosis. We found that those diagnosed before March 8th, 2020 had an overall CFR of around 20%. Future studies with longer follow-up will better clarify this aspect including studies evaluating overall population excess mortality, which will also be more comparable across countries.

Surveillance data shows clearly a very high number of COVID-19 cases among HCW, underlining the fact that SARS-CoV-2 can be easily spread in health care contexts and the importance of strong infection prevention and control practices. In Italy, as described in other countries (26), nursing homes and long term care facilities have emerged as particularly fragile environments in which infection can spread very rapidly with potentially more severe outcomes due to the vulnerability of the hosted populations (27). Affected HCW, compared with the affected general population, are on average younger and more frequently female. Considering the predominance of female professionals in working age in the Italian health sector, this is the distribution that would be expected in professionally exposed groups. Age and sex only explains in part the lower CFR, as a lower AOR of death was observed among HCW also after adjusting for those variables and might be related to earlier detection and management.

The data collected from the Italian integrated COVID-19 surveillance system during the initial phase of the emergency presents a number of limitations mainly due to completeness challenges. For this reason, some stratifications and analysis were not shown. The lack of completeness on the presence and type of comorbidities, did not allow us to include this in the multivariable analysis of deaths in order to assess, and/or adjust for, this factor. Data on hospitalisation and ICU admissions as well as CFRs are not adjusted for the expected time for disease evolution and might therefore be under-estimated in the more recent period. Finally, the estimation of R0, Rt and the doubling time were performed in regions selected on the basis of the robustness of data considering epidemiologically diverse settings.

Even in the presence of the mentioned limitations, our analysis suggests that the SARS-CoV-2 transmission potential in Italy is decreasing, albeit with large diversities across the country. Further, we observe that as of March 8 2020, the Rt it is still above the epidemic threshold. The progressively harsh physical distancing measures enacted since then may have enhanced the decreasing trend in transmissibility as happened in China [19,20]. The surveillance system will be key to monitor the effect of the implemented policies and guide the public health response as Italy will enter the second phase of its outbreak.

PUTTING RESEARCH INTO CONTEXT

Evidence before the widespread sustained local transmission of COVID-19 in Italy was largely based on the experience shared by China (2,3) and specific other countries in Asia, while evidence in Europe was initially limited to small local clusters in Germany, France (5,6) and the UK (7). While some commentaries have been issued regarding the evolving situation in Italy (25) and initial studies are available on the epidemic in the first affected region Lombardia (8,9) or based on different modelling approaches, there has been yet no communication to the scientific community of the Italian epidemiological situation at national level based on surveillance data. In this paper, we summarize key epidemiological findings from data on the first 62,843 confirmed COVID-19 cases in Italy, including 5,541 associated deaths, and initial findings on SARS-CoV-2 transmissibility across different regions. The added value of this study is of providing an in depth review of the first month of the Italian outbreak through descriptive and analytic epidemiology and an estimation of the R0 and Rt taking into account the diversity of transmission across the country. We believe that the evidence collected in Italy, with a demographic structure and health system organization that differs from those of other countries that had reported sustained disease transmission, can be of support to countries currently experiencing initial or escalating COVID-19 transmission.

Data Availability

All data referred to in the manuscript are collected through the national integrated surveillance system for COVID-19 in Italy

Supplementary materials

Figure 1
  • Download figure
  • Open in new tab
Figure 1 Map of the 21 Italian regions and autonomous provinces
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1 Distribution of diagnosed COVID-19 cases (n= 62,843), crude and adjusted Attack Rates, by Region/AP, Italy, 24 March 2020

ESTIMATION OF THE REPRODUCTION NUMBER

The basic reproduction number R0 represents the average number of secondary cases generated by a primary infector in a fully susceptible population. In general terms, when R0 is larger than 1 the infection may spread in the population and the larger R0 the larger effort required to control the epidemic. Once the number of susceptible individuals declines, the transmission potential of the disease at a given time t is measured in terms of the net reproduction number R(t). The net reproduction number is useful to track the effectiveness of performed control measures and other factors affecting the spread of the epidemic (e.g., the behavioral response of the population) over time. As soon as R(t) falls below 1, the epidemic starts to decline.

To estimate R(t), we use the same methodology presented in reference [1-3]. We assumed that the daily number of new cases (date of symptom onset) with locally acquired infection L(t) can be approximated by a Poisson distribution according to the equation Embedded Image where

  • C(t), with t from 1 to T, is daily number of new cases (date of symptom onset);

  • R(t) is the net reproduction number at time t;

  • φ(s) is the distribution of the generation time (corresponding to the distribution of the serial interval) calculated at time s. From the analysis of 90 observations of individual serial intervals in 55 clusters, the distribution of the serial interval was estimated to follow a gamma distribution with mean 6.6 days (percentiles 2.5th and 97.5th of the distribution: 0.7-19.0) [4].

The likelihood ℒ of the observed time series of cases from day 1 to day T conditional on C(0) is thus given by Embedded Image where P(k; λ) is the probability mass function of a Poisson distribution (i.e., the probability of observing k events if these events occur with rate λ).

We then used MCMC Metropolis-Hastings sampling to estimate the posterior distribution of R(t). To estimate R0, we assumed that during the period where the epidemic showed exponential growth R(t)=R0 and used the above described procedure.

Footnotes

  • ↵# senior authors

  • ↵§ Members of the COVID-19 working group

    Angela de Martino, Marzia Facchini, Stefania Giannitelli, Fabiola Mancini, Simona Puzelli, Roberta Urciuoli (Istituto Superiore di Sanità).

    Regional representatives: Antonia Petrucci (Abruzzo); Michele Labianca (Basilicata); Anna Domenica Mignuoli (Calabria); Angelo D’Argenzio (Campania); Erika Massimiliani (Emilia-Romagna); Tolinda Gallo (Friuli Venezia Giulia); Paola Scognamiglio (Lazio); Camilla Sticchi (Liguria); Danilo Cereda (Lombardia); Daniel Fiacchini (Marche); Francesco Sforza (Molise); Maria Grazia Zuccaro (P.A. Bolzano); Pier Paolo Benetollo (P.A. Trento); Donatella Tiberti (Piemonte); Maria Chironna (Puglia); Maria Antonietta Palmas (Sardegna); Salvatore Scondotto (Sicilia); Emanuela Balocchini (Toscana); Anna Tosti (Umbria); Mauro Ruffier (Valle D’Aosta); Filippo Da Re (Veneto).

  • Statements: No conflict of interest is declared

  • Funding: routine institutional funding was used to perform this work.

References

  1. 1.↵
    Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. Jan 2020;S0140673620301835.
  2. 2.↵
    Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 15 Feb 2020;395(10223):507–13.
    OpenUrlCrossRef
  3. 3.↵
    Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet [Internet]. 24 Jan 2020 [quoted 26 Jan 2020];0(0). Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/abstract
  4. 4.↵
    Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. 1 Jan 2020;doi:2020.02.07.937862.
    OpenUrlCrossRef
  5. 5.↵
    Stoecklin SB, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Eurosurveillance. 13 Feb 2020;25(6):2000094.
    OpenUrl
  6. 6.↵
    Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 30 Jan 2020;0(0):null.
  7. 7.↵
    Moss P, Barlow G, Easom N, Lillie P, Samson A. Lessons for managing high-consequence infections from first COVID-19 cases in the UK. The Lancet. 14 Mar 2020;395(10227):e46.
    OpenUrl
  8. 8.↵
    Guzzetta G, Poletti P, Ajelli M, Trentini F, Marziano V, Cereda D, et al. Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020. Eurosurveillance. 26 Mar 2020;25(12):2000293.
    OpenUrl
  9. 9.↵
    Cereda D, Tirani M, Rovida F, Demicheli V, Ajelli M, Poletti P, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. ArXiv200309320 Q-Bio [Internet]. 20 Mar 2020 [citato 28 marzo 2020]; Available at: http://arxiv.org/abs/2003.09320
  10. 10.↵
    Decree of the Prime Minister. Disposizioni attuative del decreto-legge 23 febbraio 2020, n. 6, recante misure urgenti in materia di contenimento e gestione dell’emergenza epidemiologica da COVID-19. (20A01228) (G.U. Serie Generale, n. 45 del 23 febbraio 2020) [Internet]. 2020 [quoted 19 Mar 2020]. Available at: http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=73196&articolo=6
  11. 11.↵
    Decree of the Prime Minister. Ulteriori disposizioni attuative del decreto-legge 23 febbraio 2020, n. 6, recante misure urgenti in materia di contenimento e gestione dell’emergenza epidemiologica da COVID-19, applicabili sull’intero territorio nazionale. (20A01605) (G.U. Serie Generale, n. 64 del 11 marzo 2020) [Internet]. 2020 [quoted 19 Mar 2020]. Available at: http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=73643
  12. 12.↵
    Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Eurosurveillance. 5 Mar 2020;25(9):2000178.
    OpenUrl
  13. 13.↵
    Case definition and European surveillance for COVID-19, as of 2 March 2020 [Internet]. European Centre for Disease Prevention and Control. [quoted 28 Mar 2020]. Available at: https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-human-infection-novel-coronavirus-2019-ncov
  14. 14.↵
    Stefanelli P, Faggioni G, Presti AL, Fiore S, Marchi A, Benedetti E, et al. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Eurosurveillance. 2 Apr 2020;25(13):2000305.
    OpenUrl
  15. 15.↵
    Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 23 Jan 2020;25(3):2000045.
    OpenUrl
  16. 16.↵
    CDC. 2019 Novel Coronavirus (2019-nCoV) [Internet]. Centers for Disease Control and Prevention. 2020 [quoted 20 Feb 2020]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html
  17. 17.↵
    Italian Ministry of Health. Ministerial Decree N. 0007922 - COVID-19. Aggiornamento della definizione di caso [Internet]. 2020. Available at: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2020&codLeg=73669&parte=1%20&serie=null
  18. 18.↵
    EpiCentro. Integrated surveillance of COVID-19: main national data [Internet]. [quoted 19 Mar 2020]. Available at: https://www.epicentro.iss.it/coronavirus/sars-cov-2-sorveglianza-dati
  19. 19.↵
    Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections. N Engl J Med. 16 Oct 2014;371(16):1481–95.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Liu Q-H, Ajelli M, Aleta A, Merler S, Moreno Y, Vespignani A. Measurability of the epidemic reproduction number in data-driven contact networks. Proc Natl Acad Sci. 11 Dec 2018;115(50):12680–5.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, et al. Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study. medRxiv. 23 Feb 2020;2020.02.21.20026328.
  22. 22.↵
    Demographic statistics - Italian National Institute of Statistics - Istituto Nazionale di Statistica ISTAT [Internet]. [quoted 5 Apr 2020]. Available at: http://demo.istat.it/pop2019/index.html
  23. 23.↵
    Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update [Internet]. European Centre for Disease Prevention and Control. 2020 [quoted 4 Apr 2020]. Available at: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic
  24. 24.↵
    Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA [Internet]. 24 Feb 2020 [quoted 28 Mar 2020]; Available at: https://jamanetwork.com/journals/jama/fullarticle/2762130
  25. 25.↵
    Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA [Internet]. 23 Mar 2020 [quoted 28 Mar 2020]; Available at: https://jamanetwork.com/journals/jama/fullarticle/2763667
  26. 26.↵
    Barnett ML, Grabowski DC. Nursing Homes Are Ground Zero for COVID-19 Pandemic. JAMA Health Forum. 2 Mar 2020;1(3):e200369–e200369.
    OpenUrlCrossRef
  27. 27.↵
    Acidoni A, Bacigalupo I, Bellomo M. et al. National Survey on COVID-19 spread in nursing homes and long term care facilities, First report, 30 Mar 2020 [Internet]. Available at: https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-survey-rsa-rapporto.pdf

REFERENCES

  1. 1.↵
    World Health Organization Ebola Response Team, Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371(16): 1481–95.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.
    Liu Q-H, et al. Measurability of the epidemic reproduction number in data-driven contact networks. Proc Natl Acad Sci USA 2018; 115(50): 12680.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Zhang J, et al. Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study. medRxiv 2020; doi: https://doi.org/10.1101/2020.02.21.20026328
  4. 4.↵
    Cereda D, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. 23 Mar 2020. Available from: https://arxiv.org/abs/2003.09320

REFERENCES OF THE R PACKAGES USED

  1. Achim Zeileis, Yves Croissant (2010). Extended Model Formulas in R: Multiple Parts and Multiple Responses. Journal of Statistical Software 34(1), 1–13. doi:10.18637/jss.v034.i01
    OpenUrlCrossRef
  2. Alastair Rushworth (2019). inspectdf: Inspection, Comparison and Visualisation of Data Frames. R package version 0.0.7. https://CRAN.R-project.org/package=inspectdf
  3. David Gohel (2020). officer: Manipulation of Microsoft Word and PowerPoint Documents. R package version 0.3.8. https://CRAN.R-project.org/package=officer
  4. David Gohel (2020). rvg: R Graphics Devices for Vector Graphics Output. R package version 0.2.4. https://CRAN.R-project.org/package=rvg
  5. David Robinson and Alex Hayes (2020). broom: Convert Statistical Analysis Objects into Tidy Tibbles. R package version 0.5.5. https://CRAN.R-project.org/package=broom
  6. Frank E Harrell Jr., with contributions from Charles Dupont and many others. (2020). Hmisc: Harrell Miscellaneous. R package version 4.3-1. https://CRAN.R-project.org/package=Hmisc
  7. Garrett Grolemund, Hadley Wickham (2011). Dates and Times Made Easy with lubridate. Journal of Statistical Software, 40(3), 1-25. URL http://www.jstatsoft.org/v40/i03/.
    OpenUrl
  8. Haddley Wickham. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York, 2016.
  9. Hadley Wickham (2011). The Split-Apply-Combine Strategy for Data Analysis. Journal of Statistical Software, 40(1), 1-29. URL http://www.jstatsoft.org/v40/i01/.
    OpenUrl
  10. Hadley Wickham (2019). stringr: Simple, Consistent Wrappers for Common String Operations. R package version 1.4.0. https://CRAN.R-project.org/package=stringr
  11. Hadley Wickham (2020). forcats: Tools for Working with Categorical Variables (Factors). R package version 0.5.0. https://CRAN.R-project.org/package=forcats
  12. Hadley Wickham and Dana Seidel (2019). scales: Scale Functions for Visualization. R package version 1.1.0. https://CRAN.R-project.org/package=scales
  13. Hadley Wickham and Evan Miller (2019). haven: Import and Export ‘SPSS’, ‘Stata’ and ‘SAS’ Files. R package version 2.2.0. https://CRAN.R-project.org/package=haven
  14. Hadley Wickham and Jennifer Bryan (2019). readxl: Read Excel Files. R package version 1.3.1. https://CRAN.R-project.org/package=readxl
  15. Hadley Wickham and Lionel Henry (2020). tidyr: Tidy Messy Data. R package version 1.0.2. https://CRAN.R-project.org/package=tidyr
  16. Hadley Wickham, Jim Hester and Romain Francois (2018). readr: Read Rectangular Text Data. R package version 1.3.1. https://CRAN.R-project.org/package=readr
  17. Hadley Wickham, Romain François, Lionel Henry and Kirill Müller (2020). dplyr: A Grammar of Data Manipulation. R package version 0.8.5. https://CRAN.R-project.org/package=dplyr
  18. Jared E. Knowles (2019). eeptools: Convenience Functions for Education Data. R package version 1.2.2. https://CRAN.R-project.org/package=eeptools
  19. Jim Hester (2020). glue: Interpreted String Literals. R package version 1.3.2. https://CRAN.R-project.org/package=glue
  20. Kamvar ZN, Cai J, Pulliam JRC, Schumacher J, Jombart T. Epidemic curves made easy using the R package incidence [version 1; referees: awaiting peer review]. F1000Research 2019, 8:139. URL https://doi.org/10.12688/f1000research.18002.1.
    OpenUrl
  21. Kirill Müller and Hadley Wickham (2019). tibble: Simple Data Frames. R package version 2.1.3. https://CRAN.R-project.org/package=tibble
  22. Lionel Henry and Hadley Wickham (2019). purrr: Functional Programming Tools. R package version 0.3.3. https://CRAN.R-project.org/package=purrr
  23. Makowski, D. & Lüdecke, D. (2019). The report package for R: Ensuring the use of best practices for results reporting. CRAN. Available from https://github.com/easystats/report. doi:.
  24. Nowosad, J. (2018). ‘CARTOColors’ Palettes. R package version 1.0.0. https://nowosad.github.io/rcartocolor
  25. Pebesma, E., 2018. Simple Features for R: Standardized Support for Spatial Vector Data. The R Journal 10 (1), 439–446, https://doi.org/10.32614/RJ-2018-009
    OpenUrl
  26. Sam Firke (2020). janitor: Simple Tools for Examining and Cleaning Dirty Data. R package version 1.2.1. https://CRAN.R-project.org/package=janitor
  27. Sarkar, Deepayan (2008) Lattice: Multivariate Data Visualization with R. Springer, New York. ISBN 978-0-387-75968-5
  28. Simon Garnier (2018). viridisLite: Default Color Maps from ‘matplotlib’ (Lite Version). R package version 0.3.0. https://CRAN.R-project.org/package=viridisLite
  29. Therneau T (2015). _A Package for Survival Analysis in S_. version 2.38, https://CRAN.R-project.org/package=survival.
  30. Thomas Lin Pedersen (2019). patchwork: The Composer of Plots. R package version 1.0.0. https://CRAN.R-project.org/package=patchwork
  31. Tomas J. Aragon (2020). epitools: Epidemiology Tools. R package version 0.5-10.1. https://CRAN.R-project.org/package=epitools
  32. Wickham et al., (2019). Welcome to the tidyverse. Journal of Open Source Software, 4(43), 1686, https://doi.org/10.21105/joss.01686
    OpenUrl
  33. Yihui Xie (2020). knitr: A General-Purpose Package for Dynamic Report Generation in R. R package version 1.28.
Back to top
PreviousNext
Posted April 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic
Flavia Riccardo, Marco Ajelli, Xanthi D Andrianou, Antonino Bella, Martina Del Manso, Massimo Fabiani, Stefania Bellino, Stefano Boros, Alberto Mateo Urdiales, Valentina Marziano, Maria Cristina Rota, Antonietta Filia, Fortunato Paolo D’Ancona, Andrea Siddu, Ornella Punzo, Filippo Trentini, Giorgio Guzzetta, Piero Poletti, Paola Stefanelli, Maria Rita Castrucci, Alessandra Ciervo, Corrado Di Benedetto, Marco Tallon, Andrea Piccioli, Silvio Brusaferro, Giovanni Rezza, Stefano Merler, Patrizio Pezzotti, for the COVID-19 working group
medRxiv 2020.04.08.20056861; doi: https://doi.org/10.1101/2020.04.08.20056861
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic
Flavia Riccardo, Marco Ajelli, Xanthi D Andrianou, Antonino Bella, Martina Del Manso, Massimo Fabiani, Stefania Bellino, Stefano Boros, Alberto Mateo Urdiales, Valentina Marziano, Maria Cristina Rota, Antonietta Filia, Fortunato Paolo D’Ancona, Andrea Siddu, Ornella Punzo, Filippo Trentini, Giorgio Guzzetta, Piero Poletti, Paola Stefanelli, Maria Rita Castrucci, Alessandra Ciervo, Corrado Di Benedetto, Marco Tallon, Andrea Piccioli, Silvio Brusaferro, Giovanni Rezza, Stefano Merler, Patrizio Pezzotti, for the COVID-19 working group
medRxiv 2020.04.08.20056861; doi: https://doi.org/10.1101/2020.04.08.20056861

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (242)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1428)
  • Dentistry and Oral Medicine (218)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (587)
  • Epidemiology (10317)
  • Forensic Medicine (6)
  • Gastroenterology (531)
  • Genetic and Genomic Medicine (2643)
  • Geriatric Medicine (254)
  • Health Economics (499)
  • Health Informatics (1742)
  • Health Policy (791)
  • Health Systems and Quality Improvement (678)
  • Hematology (269)
  • HIV/AIDS (569)
  • Infectious Diseases (except HIV/AIDS) (12110)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (274)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2473)
  • Nursing (145)
  • Nutrition (380)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1329)
  • Ophthalmology (403)
  • Orthopedics (150)
  • Otolaryngology (238)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (331)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2412)
  • Public and Global Health (5022)
  • Radiology and Imaging (897)
  • Rehabilitation Medicine and Physical Therapy (531)
  • Respiratory Medicine (685)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (299)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)